Similar articles

• Neoadjuvant (induction) chemotherapy in advanced bladder carcinoma.

  Türkeri L, Ilker Y, Simşek F, Akdaş A. Türkeri L, et al. Int Urol Nephrol. 1993;25(3):259-63. Int Urol Nephrol. 1993. PMID: 8225827 Review.
• Neo-adjuvant M-VAC (methotrexate, vinblastine, adriamycin, and cisplatin) for infiltrating bladder cancer: initial results in Italy.

  Sternberg CN. Sternberg CN. Prog Clin Biol Res. 1990;353:143-52. Prog Clin Biol Res. 1990. PMID: 2217412 Review. No abstract available.
• Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.

  Walther PJ. Walther PJ. Semin Urol. 1993 Nov;11(4):227-34. Semin Urol. 1993. PMID: 8290828 Review. No abstract available.
• Neoadjuvant treatment for invasive bladder cancer: is it worthwhile?

  Hall RR. Hall RR. Acta Urol Belg. 1996 May;64(2):39-42. Acta Urol Belg. 1996. PMID: 8701809 No abstract available.
• Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer.

  Sternberg CN, Parmar MK. Sternberg CN, et al. J Clin Oncol. 2001 Sep 15;19(18 Suppl):21S-26S. J Clin Oncol. 2001. PMID: 11560967 No abstract available.